Determinants of dyslipidaemia in probands with polycystic ovary syndrome and their sisters.
about
Complications and challenges associated with polycystic ovary syndrome: current perspectivesPolycystic Ovary Syndrome: Important Underrecognised Cardiometabolic Risk Factor in Reproductive-Age WomenScientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.Cardiometabolic aspects of the polycystic ovary syndrome.Metabolic syndrome, hypertension, and hyperlipidemia in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis.Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.
P2860
Determinants of dyslipidaemia in probands with polycystic ovary syndrome and their sisters.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Determinants of dyslipidaemia ...... ry syndrome and their sisters.
@ast
Determinants of dyslipidaemia ...... ry syndrome and their sisters.
@en
type
label
Determinants of dyslipidaemia ...... ry syndrome and their sisters.
@ast
Determinants of dyslipidaemia ...... ry syndrome and their sisters.
@en
prefLabel
Determinants of dyslipidaemia ...... ry syndrome and their sisters.
@ast
Determinants of dyslipidaemia ...... ry syndrome and their sisters.
@en
P2093
P2860
P1476
Determinants of dyslipidaemia ...... ry syndrome and their sisters.
@en
P2093
Gerard S Conway
Jalini Joharatnam
Lisa Webber
Stephen Franks
Thomas M Barber
P2860
P304
P356
10.1111/J.1365-2265.2011.03983.X
P577
2011-06-01T00:00:00Z